{"entity":{"type":"insider","cik":"0001604800","url":"/insider/0001604800","json_url":"/insider/0001604800.json","name":"Smith Jeffrey T L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":32,"first":"2014-11-25","last":"2026-01-12","span_basis":"filed_date"},"name_variants":[{"name":"Smith Jeffrey T L","source":"filing","n_filings":32,"first_seen":"2014-11-25","last_seen":"2026-01-12"}],"transactions":[{"id":5836150,"accession":"0001193125-26-010865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-010865","line_url":"/filing/0001193125-26-010865#line-2","is_derivative":false,"issuer_cik":"0001604800","issuer_name":"Zymeworks Inc.","issuer_ticker":"ZYME","issuer_name_source":null,"issuer_url":"/issuer/0001604800","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9310.0,"shares_display":"9,310","price_per_share":22.6735,"price_display":"22.67","price_state":"stated","total_value":211090.285,"total_display":"211,090.28","total_whole":"211,090","shares_owned_after":26708.0,"shares_owned_after_display":"26,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-12","scope":"insider"},{"id":5762083,"accession":"0001193125-26-003102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-003102","line_url":"/filing/0001193125-26-003102#line-2","is_derivative":false,"issuer_cik":"0001604800","issuer_name":"Zymeworks Inc.","issuer_ticker":"ZYME","issuer_name_source":null,"issuer_url":"/issuer/0001604800","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10538.0,"shares_display":"10,538","price_per_share":25.0969,"price_display":"25.10","price_state":"stated","total_value":264471.1322,"total_display":"264,471.13","total_whole":"264,471","shares_owned_after":18352.0,"shares_owned_after_display":"18,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":4047231,"accession":"0000950170-25-002490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-002490","line_url":"/filing/0000950170-25-002490#line-2","is_derivative":false,"issuer_cik":"0001604800","issuer_name":"Zymeworks Inc.","issuer_ticker":"ZYME","issuer_name_source":null,"issuer_url":"/issuer/0001604800","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (EVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11110.0,"shares_display":"11,110","price_per_share":14.9241,"price_display":"14.92","price_state":"stated","total_value":165806.751,"total_display":"165,806.75","total_whole":"165,807","shares_owned_after":8890.0,"shares_owned_after_display":"8,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-06","scope":"insider"},{"id":8519477,"accession":"0001209191-19-050079","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-050079","line_url":"/filing/0001209191-19-050079#line-3","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Managing Director)","role_mark":"O","role_mark_label":"Officer (Managing Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Managing Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32728.0,"shares_display":"32,728","price_per_share":18.44,"price_display":"18.44","price_state":"stated","total_value":603504.32,"total_display":"603,504.32","total_whole":"603,504","shares_owned_after":5272.0,"shares_owned_after_display":"5,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-16","filed_date":"2019-09-18","scope":"insider"},{"id":6338256,"accession":"0001209191-18-061036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-061036","line_url":"/filing/0001209191-18-061036#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Managing Director)","role_mark":"O","role_mark_label":"Officer (Managing Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Managing Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5044.0,"shares_display":"5,044","price_per_share":13.8434,"price_display":"13.84","price_state":"stated","total_value":69826.1096,"total_display":"69,826.11","total_whole":"69,826","shares_owned_after":831.0,"shares_owned_after_display":"831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-04","scope":"insider"},{"id":6869533,"accession":"0001209191-18-057264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-057264","line_url":"/filing/0001209191-18-057264#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Managing Director)","role_mark":"O","role_mark_label":"Officer (Managing Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Managing Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5040.0,"shares_display":"5,040","price_per_share":13.42,"price_display":"13.42","price_state":"stated","total_value":67636.8,"total_display":"67,636.80","total_whole":"67,637","shares_owned_after":831.0,"shares_owned_after_display":"831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-05","scope":"insider"},{"id":6707931,"accession":"0001209191-18-054090","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-054090","line_url":"/filing/0001209191-18-054090","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Managing Director)","role_mark":"O","role_mark_label":"Officer (Managing Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Managing Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5040.0,"shares_display":"5,040","price_per_share":15.541553968253968,"price_display":"15.54","price_state":"stated","total_value":78329.432,"total_display":"78,329.43","total_whole":"78,329","shares_owned_after":2831.0,"shares_owned_after_display":"2,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-03","scope":"insider","n_lines":2},{"id":6156141,"accession":"0001209191-18-049877","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-049877","line_url":"/filing/0001209191-18-049877#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Managing Director)","role_mark":"O","role_mark_label":"Officer (Managing Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Managing Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5040.0,"shares_display":"5,040","price_per_share":17.9958,"price_display":"18.00","price_state":"stated","total_value":90698.832,"total_display":"90,698.83","total_whole":"90,699","shares_owned_after":831.0,"shares_owned_after_display":"831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6726549,"accession":"0001209191-18-045042","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-045042","line_url":"/filing/0001209191-18-045042","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Managing Director)","role_mark":"O","role_mark_label":"Officer (Managing Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Managing Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5040.0,"shares_display":"5,040","price_per_share":19.54146666666667,"price_display":"19.54","price_state":"stated","total_value":98488.992,"total_display":"98,488.99","total_whole":"98,489","shares_owned_after":1811.0,"shares_owned_after_display":"1,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-01","filed_date":"2018-08-02","scope":"insider","n_lines":2},{"id":6661053,"accession":"0001209191-18-041240","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-041240","line_url":"/filing/0001209191-18-041240#line-3","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Managing Director)","role_mark":"O","role_mark_label":"Officer (Managing Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Managing Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12161.0,"shares_display":"12,161","price_per_share":15.4892,"price_display":"15.49","price_state":"stated","total_value":188364.1612,"total_display":"188,364.16","total_whole":"188,364","shares_owned_after":831.0,"shares_owned_after_display":"831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-03","scope":"insider"},{"id":6291753,"accession":"0001209191-18-035868","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-035868","line_url":"/filing/0001209191-18-035868","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Managing Director)","role_mark":"O","role_mark_label":"Officer (Managing Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Managing Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12161.0,"shares_display":"12,161","price_per_share":17.85436521667626,"price_display":"17.85","price_state":"stated","total_value":217126.9354,"total_display":"217,126.94","total_whole":"217,127","shares_owned_after":1931.0,"shares_owned_after_display":"1,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-05","scope":"insider","n_lines":2},{"id":6558215,"accession":"0001209191-18-031528","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-031528","line_url":"/filing/0001209191-18-031528#line-3","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Managing Director)","role_mark":"O","role_mark_label":"Officer (Managing Director)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Managing Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12161.0,"shares_display":"12,161","price_per_share":15.0282,"price_display":"15.03","price_state":"stated","total_value":182757.9402,"total_display":"182,757.94","total_whole":"182,758","shares_owned_after":831.0,"shares_owned_after_display":"831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-18","scope":"insider"},{"id":4742705,"accession":"0001209191-17-041449","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-041449","line_url":"/filing/0001209191-17-041449#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":585.0,"shares_display":"585","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":11700.0,"total_display":"11,700.00","total_whole":"11,700","shares_owned_after":831.0,"shares_owned_after_display":"831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-20","filed_date":"2017-06-22","scope":"insider"},{"id":2890846,"accession":"0001209191-16-153491","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-153491","line_url":"/filing/0001209191-16-153491","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":22.776,"price_display":"22.78","price_state":"stated","total_value":68328.0,"total_display":"68,328.00","total_whole":"68,328","shares_owned_after":1331.0,"shares_owned_after_display":"1,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider","n_lines":2},{"id":2378543,"accession":"0001209191-16-148271","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-148271","line_url":"/filing/0001209191-16-148271","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":24.343993333333334,"price_display":"24.34","price_state":"stated","total_value":73031.98,"total_display":"73,031.98","total_whole":"73,032","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-01","filed_date":"2016-11-03","scope":"insider","n_lines":2},{"id":2702914,"accession":"0001209191-16-145140","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-145140","line_url":"/filing/0001209191-16-145140","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":31.1383008,"price_display":"31.14","price_state":"stated","total_value":93414.9024,"total_display":"93,414.90","total_whole":"93,415","shares_owned_after":702.0,"shares_owned_after_display":"702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider","n_lines":2},{"id":2325300,"accession":"0001209191-16-140247","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-140247","line_url":"/filing/0001209191-16-140247","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":32.49438333333333,"price_display":"32.49","price_state":"stated","total_value":97483.15,"total_display":"97,483.15","total_whole":"97,483","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-06","scope":"insider","n_lines":2},{"id":2926500,"accession":"0001209191-16-137645","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-137645","line_url":"/filing/0001209191-16-137645#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":31.1708,"price_display":"31.17","price_state":"stated","total_value":93512.4,"total_display":"93,512.40","total_whole":"93,512","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider"},{"id":3210595,"accession":"0001209191-16-126363","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-126363","line_url":"/filing/0001209191-16-126363","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16090.0,"shares_display":"16,090","price_per_share":30.200956370416407,"price_display":"30.20","price_state":"stated","total_value":485933.388,"total_display":"485,933.39","total_whole":"485,933","shares_owned_after":4805.0,"shares_owned_after_display":"4,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-03","filed_date":"2016-06-07","scope":"insider","n_lines":3},{"id":8775185,"accession":"0001209191-15-083421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-083421","line_url":"/filing/0001209191-15-083421#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4272.0,"shares_display":"4,272","price_per_share":37.2434,"price_display":"37.24","price_state":"stated","total_value":159103.8048,"total_display":"159,103.80","total_whole":"159,104","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":8189900,"accession":"0001209191-15-078575","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-078575","line_url":"/filing/0001209191-15-078575","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":33.666464102564106,"price_display":"33.67","price_state":"stated","total_value":131299.21,"total_display":"131,299.21","total_whole":"131,299","shares_owned_after":2400.0,"shares_owned_after_display":"2,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-04","scope":"insider","n_lines":3},{"id":8346128,"accession":"0001209191-15-074091","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-074091","line_url":"/filing/0001209191-15-074091","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":32.25074358974359,"price_display":"32.25","price_state":"stated","total_value":125777.9,"total_display":"125,777.90","total_whole":"125,778","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-01","filed_date":"2015-10-05","scope":"insider","n_lines":2},{"id":8301604,"accession":"0001209191-15-069520","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-069520","line_url":"/filing/0001209191-15-069520","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":38.503853846153845,"price_display":"38.50","price_state":"stated","total_value":150165.03,"total_display":"150,165.03","total_whole":"150,165","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-01","filed_date":"2015-09-03","scope":"insider","n_lines":2},{"id":8904210,"accession":"0001209191-15-064179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-064179","line_url":"/filing/0001209191-15-064179#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":45.6418,"price_display":"45.64","price_state":"stated","total_value":178003.02,"total_display":"178,003.02","total_whole":"178,003","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-05","scope":"insider"},{"id":8416996,"accession":"0001209191-15-059681","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-059681","line_url":"/filing/0001209191-15-059681#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":51.1836,"price_display":"51.18","price_state":"stated","total_value":199616.04,"total_display":"199,616.04","total_whole":"199,616","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-06","scope":"insider"},{"id":8461127,"accession":"0001209191-15-049869","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-049869","line_url":"/filing/0001209191-15-049869#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":41.5304,"price_display":"41.53","price_state":"stated","total_value":161968.56,"total_display":"161,968.56","total_whole":"161,969","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider"},{"id":8577235,"accession":"0001209191-15-046930","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-046930","line_url":"/filing/0001209191-15-046930#line-4","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7202.0,"shares_display":"7,202","price_per_share":38.4653,"price_display":"38.47","price_state":"stated","total_value":277027.0906,"total_display":"277,027.09","total_whole":"277,027","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-22","filed_date":"2015-05-26","scope":"insider"},{"id":8577224,"accession":"0001209191-15-046930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-046930","line_url":"/filing/0001209191-15-046930#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54616.0,"shares_display":"54,616","price_per_share":38.9171,"price_display":"38.92","price_state":"stated","total_value":2125496.3336,"total_display":"2,125,496.33","total_whole":"2,125,496","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-21","filed_date":"2015-05-26","scope":"insider"},{"id":8826265,"accession":"0001209191-15-039053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-039053","line_url":"/filing/0001209191-15-039053#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":25.6743,"price_display":"25.67","price_state":"stated","total_value":100129.77,"total_display":"100,129.77","total_whole":"100,130","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-01","filed_date":"2015-05-05","scope":"insider"},{"id":8575517,"accession":"0001209191-15-032444","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-032444","line_url":"/filing/0001209191-15-032444#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":27.4346,"price_display":"27.43","price_state":"stated","total_value":106994.94,"total_display":"106,994.94","total_whole":"106,995","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-01","filed_date":"2015-04-03","scope":"insider"},{"id":8669278,"accession":"0001209191-15-022398","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-022398","line_url":"/filing/0001209191-15-022398#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":26.2454,"price_display":"26.25","price_state":"stated","total_value":102357.06,"total_display":"102,357.06","total_whole":"102,357","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-04","scope":"insider"},{"id":8456962,"accession":"0001209191-15-007135","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-007135","line_url":"/filing/0001209191-15-007135#line-4","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":28.2679,"price_display":"28.27","price_state":"stated","total_value":33921.48,"total_display":"33,921.48","total_whole":"33,921","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-27","filed_date":"2015-01-28","scope":"insider"},{"id":8456955,"accession":"0001209191-15-007135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-007135","line_url":"/filing/0001209191-15-007135#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":27.8948,"price_display":"27.89","price_state":"stated","total_value":75315.96,"total_display":"75,315.96","total_whole":"75,316","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-26","filed_date":"2015-01-28","scope":"insider"},{"id":7016261,"accession":"0001209191-14-071276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-071276","line_url":"/filing/0001209191-14-071276#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9090.0,"shares_display":"9,090","price_per_share":16.9125,"price_display":"16.91","price_state":"stated","total_value":153734.625,"total_display":"153,734.62","total_whole":"153,735","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-25","scope":"insider"},{"id":7016259,"accession":"0001209191-14-071276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-071276","line_url":"/filing/0001209191-14-071276#line-1","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604800","owner_name":"Smith Jeffrey T L","owner_display_name":"Smith Jeffrey T L","owner_url":"/insider/0001604800","role":"Officer (Sr. VP Translational Medicine)","role_mark":"O","role_mark_label":"Officer (Sr. VP Translational Medicine)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP Translational Medicine","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":15.7059,"price_display":"15.71","price_state":"stated","total_value":314118.0,"total_display":"314,118.00","total_whole":"314,118","shares_owned_after":9090.0,"shares_owned_after_display":"9,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-21","filed_date":"2014-11-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":48,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001937653","name":"Zymeworks Inc.","url":"/issuer/0001937653","role":"Officer (EVP & Chief Medical Officer)","n_filings":3,"first_seen":"2025-01-06","last_seen":"2026-01-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001423824","name":"ALDER BIOPHARMACEUTICALS INC","url":"/issuer/0001423824","role":"Officer (Managing Director)","n_filings":29,"first_seen":"2014-11-25","last_seen":"2019-09-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001604800","retrieved_at":"2026-08-25T21:19:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}